These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31258)

  • 1. Metabolism of drugs and carcinogens in man: antipyrine elimination as an indicator.
    Kalamegham R; Krishnaswamy K; Krishnamurthy S; Bhargava RN
    Clin Pharmacol Ther; 1979 Jan; 25(1):67-73. PubMed ID: 31258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative metabolism of benzo[a]pyrene and drugs in human liver.
    Kapitulnik J; Popper PJ; Conney AH
    Clin Pharmacol Ther; 1977 Feb; 21(2):166-76. PubMed ID: 837635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo.
    Pelkonen O; Sotaniemi E; Tokola O; Ahokas JT
    Drug Metab Dispos; 1980; 8(4):218-22. PubMed ID: 6105054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.
    Vuitton D; Miguet JP; Camelot G; Delafin C; Joanne C; Bechtel P; Gillet M; Carayon P
    Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cigarette smoking and drug metabolism.
    Vähäkangas K; Pelkonen O; Sotaniemi E
    Clin Pharmacol Ther; 1983 Mar; 33(3):375-80. PubMed ID: 6825392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipyrine clearance, aminopyrine N-demethylase, and bilirubin UDP-glucuronyl transferase activity in patients with amoebic liver abscess.
    Narang AP; Datta DV; Mathur VS
    Biopharm Drug Dispos; 1982; 3(1):39-45. PubMed ID: 7082778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cimetidine on microsomal drug metabolism in man.
    Puurunen J; Sotaniemi E; Pelkonen O
    Eur J Clin Pharmacol; 1980 Aug; 18(2):185-7. PubMed ID: 7428801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of indomethacin on hepatic drug-oxidizing capacity in the rat: trimethadione and antipyrine metabolism as an indicator.
    Tanaka E; Kobayashi S; Aramphongphan A; Kurata N; Oguchi K; Kuroiwa Y; Yasuhara H
    J Pharmacobiodyn; 1985 Sep; 8(9):773-9. PubMed ID: 4087137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of hepatic drug metabolism in patients with acute viral hepatitis.
    Narang AP; Datta DV; Nath N; Mathur VS
    Eur J Drug Metab Pharmacokinet; 1982; 7(4):255-8. PubMed ID: 7166177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in drug metabolism in workers exposed to polychlorinated biphenyls.
    Alvares AP; Fischbein A; Anderson KE; Kappas A
    Clin Pharmacol Ther; 1977 Aug; 22(2):140-6. PubMed ID: 407043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of praziquantel treatment on the activities of some liver microsomal enzymes in mice infected with Schistosoma mansoni.
    Ezzat AR; el-Din SH; Ebeid FA
    Arzneimittelforschung; 2001; 51(4):325-31. PubMed ID: 11367874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between antipyrine and aminopyrine.
    Vesell ES; Passananti GT; Hepner GW
    Clin Pharmacol Ther; 1976 Dec; 20(6):661-9. PubMed ID: 991537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic properties of isolated rat liver cell preparations enriched in epithelial cells other than hepatocytes.
    Ledda GM; Sells MA; Yokoyama S; Lombardi B
    Int J Cancer; 1983 Feb; 31(2):231-7. PubMed ID: 6131033
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatic microsomal drug metabolism, glutamyl transferase activity and in vivo antipyrine half-life in rats chronically fed an ethanol diet, a control diet and a chow diet.
    Gadeholt G; Aarbakke J; Dybing E; Sjöblom M; Mørland J
    J Pharmacol Exp Ther; 1980 Apr; 213(1):196-203. PubMed ID: 6102148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Schistosoma mansoni infection on the hepatic drug-metabolizing capacity of mice.
    Cha YN; Edwards R
    J Pharmacol Exp Ther; 1976 Nov; 199(2):432-40. PubMed ID: 185361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Protein restriction and metabolism of xenobiotics].
    Albrecht R; Pelissier MA; Miladi N; Atteba S; Desfontaines C; Narbonne JF
    Ann Nutr Metab; 1986; 30(2):73-80. PubMed ID: 3083760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression of cytochrome P-450-dependent drug biotransformation by adriamycin.
    Marchand DJ; Renton KW
    Toxicol Appl Pharmacol; 1981 Mar; 58(1):83-8. PubMed ID: 7233442
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of estrus cycle on drug metabolism in the rat.
    Brandstetter Y; Kaplanski J; Leibson V; Ben-Zvi Z
    Eur J Drug Metab Pharmacokinet; 1986; 11(4):251-4. PubMed ID: 3582419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic profile of antipyrine in young rhesus monkeys (Macaca mulatta) with protein energy malnutrition.
    Sharma B; Mehta S; Nain CK; Mathur VS
    Drug Nutr Interact; 1985; 3(2):93-8. PubMed ID: 3921335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced drug metabolism after sulfinpyrazone treatment in patients aged 50 to 60 years.
    Walter E; Staiger C; de Vries J; Weber E; Bitzer W; Degott M; Jüngling K
    Klin Wochenschr; 1982 Nov; 60(22):1409-13. PubMed ID: 6129344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.